测量老年痴呆症患者的护理风险:一个范围审查
Liqin Wei1,2, Lihui Pu3, Jiayi Zhu1,4
1West China School of Nursing/Nursing Key Laboratory of Sichuan Province/Innovation Center of Nursing Research/West China Hospital, Sichuan University, Rm 410, Building of West China School of Medicine, Guoxuexiang 37#, Wuhou District, Chengdu City, Sichuan Province, China.
BMC geriatrics
|December 18, 2025
概括
评估老年痴呆症患者的护理风险是复杂的. 该审查确定了四个关键的风险维度 - - 身体健康,护理人员,社会支持和环境 - - 并强调需要以患者为中心的工具和纵向验证.
科学领域:
- 老年学是一门学科.
- 痴呆症护理 痴呆症护理 痴呆症护理
- 风险评估 风险评估
背景情况:
- 患有痴呆症的老年人由于复杂的个人,护理人员,环境和过程因素而面临重大护理风险.
- 目前用于评估这一群体的护理风险的方法尚未确定,因此需要进行全面的审查.
- 护理风险对痴呆症患者,他们的家庭和社会的福祉构成威胁.
研究的目的:
- 进行范围审查,以确定当前的护理风险评估工具和痴呆症老年人的前景.
- 为了提供一个全面的现有研究对护理风险评估在这个人群的综合概述.
- 突出目前研究中的重大缺陷,以供未来的研究.
主要方法:
- 坚持乔安娜·布里格斯研究所对范围审查和PRISMA检查清单的方法.
- 进行广泛的数据库搜索 (PubMed,CINAHL,科学网等) 从开始到2023年12月.
- 包括13106个已识别的文章中的16个,采用定性,定量和混合方法方法.
主要成果:
- 在文献中确定了五种不同的工具来衡量护理风险.
- 护理风险评估的关键领域包括生活环境,老年人的特征,照顾者和社会支持.
- 审查的研究采用了定性 (25%),定量 (43.75%) 和混合方法 (31.25%) 的研究设计.
结论:
- 确定了护理风险的四个主要方面:身体健康,护理人员,社会支持和环境.
- 现有的护理风险评估工具需要通过纵向研究进一步验证以确定稳定性.
- 未来的研究应该强调以患者为中心的评估观点,以改善护理风险评估.
相关概念视频
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
Drug Dosing: Geriatric Patients
209
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
209
Pharmacodynamics in Geriatric Patients: Effects of Age
175
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
175
Dementia
486
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
486
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
380
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
380
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
181
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
181


